https://doi.org/10.4081/1680

Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation

Vol. 46 No. 3 (2002)
Submitted: 23 January 2010
Accepted: 23 January 2010
Published: 23 January 2010
Abstract Views: 658
PDF: 831
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

F Cappello
support@pagepress.org
PAGEPress Office, Pavia, Italy.
M Bellafiore
A Palma
F Bucchieri
The transcription factor p53 and the cytokine receptor FasL are two of the most famous regulators of cell life, and their alterations can cause a large number of pathologies, including cancer. In this review, we focused on how they can determine defective apoptosis, one of the causes of tumorigenesis and tumor progression. The importance of this knowledge lies in the new perspectives that gene therapy can offer to cure cancer.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Cappello, F., Bellafiore, M., Palma, A., & Bucchieri, F. (2010). Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. European Journal of Histochemistry, 46(3), 199–208. https://doi.org/10.4081/1680

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.